Chronic kidney disease: effects on the cardiovascular system

Area of Science:

• Nephrology
• Cardiology
• Vascular Biology

Background:

• Accelerated cardiovascular disease is a common complication in patients with chronic kidney disease (CKD).
• CKD contributes to hypertension, dyslipidemia, and diabetes, which are key drivers of endothelial dysfunction and atherosclerosis.
• Diabetic nephropathy is a leading cause of end-stage renal disease in developed nations.

Purpose of the Study:

• To summarize the complex relationship between chronic kidney disease and accelerated cardiovascular disease.
• To highlight the mechanisms linking CKD to cardiovascular complications.
• To emphasize the importance of cardiovascular disease prevention and management in CKD patients.

Main Methods:

• Literature review and synthesis of existing research on CKD and cardiovascular disease.
• Analysis of the roles of hypertension, dyslipidemia, diabetes, inflammation, and vascular calcification in CKD-associated atherosclerosis.
• Examination of the impact of CKD on cardiovascular morbidity and mortality.

Main Results:

• CKD exacerbates atherosclerosis through factors including elevated blood pressure, abnormal lipid profiles, and diabetes.
• Inflammation and activation of the renin-angiotensin system in CKD contribute to oxidative stress and atherosclerosis.
• Altered calcification balance in CKD promotes vascular calcification and injury, particularly in end-stage renal disease.

Conclusions:

• CKD significantly increases the risk of cardiovascular events such as heart attack, heart failure, and stroke.
• Effective management of hypertension, dyslipidemia, and diabetes is essential for mitigating cardiovascular risk in CKD.
• Cardiovascular disease prevention and treatment are critical components of comprehensive CKD care to reduce patient morbidity and mortality.